Pursuant to Regulation 39(3) of the SEBI LODR Regulations and in terms of SEBI Circular No. SEBI/HO/MIRSD/ MIRSD_RTAMB/P/CIR/2022/8 dated 25th January, 2022, Ajanta Pharma has informed that the Company has approved issuance of ‘Letter of Confirmation’ on 4th August 2023 in lieu of share certificate(s), which were reported lost by the shareholder: Paridhi Shah (Folio No. 000545)
The above information is a part of company’s filings submitted to BSE.